. These effects have great implications in ischemic and pressure overload heart diseases (9).
In addition to cardiovascular disease, altered HIF signaling has been implicated in diabetes. In patients with diabetes, the expression of ARNT is lower in the pancreas and liver and genetic deletion of this protein in these 2 organs results in diabetic phenotypes (10, 11) . Cardiac expression of ARNT is also reduced in the hearts of mice with genetic and diet-induced diabetes. Cardiac-specific deletion of ARNT leads to increased peroxisome proliferator-activated receptora expression, thereby resulting in heightened lipid uptake and oxidation. The imbalance between lipid uptake and oxidation causes lipid accumulation and spontaneous cardiomyopathy (12) . This evidence demonstrates that diabetes may influence HIF signaling; at the same time, HIF signaling can modulate diabetic phenotypes.
In the heart, diabetes shifts cellular metabolism in favor of increased utilization of fatty acids (FAs) with a concomitant inhibition of glycolysis and glucose oxidation (13, 14) . FA-mediated suppression of glucose oxidation was first described by Randle et al. 
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